2 weeks Ago By ABMN Staff
Shares of Surgery Partners, Inc. ( NASDAQ:SGRY – Get Free Report ) have been assigned a consensus rating of “Moderate Buy” from the seven analysts that are presently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a hold rating and six have given a buy rating to the company.
The average 1 year target price among analysts that have issued a report on the stock in the last year is $39.86. A number of research analysts have recently commented on SGRY shares.
Macquarie started coverage on Surgery Partners in a research report on Friday, June 28th. They set an “outperform” rating and a $31.00 price target on the stock.
Benchmark reaffirmed a “buy” rating and set a $50.00 price target on shares of Surgery Partners in a research report on Monday, August 26th. StockNews.
com cut Surgery Partners from a “hold” rating to a “sell” rating in a research report on Wednesday, August 7th. Citigroup dropped their price target on Surgery Partners from $38.00 to $36.
00 and set a “buy” rating on the stock in a research report on Wednesday, August 7th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and set a $49.00 price target on shares of Surgery Partners in a research report on Wednesday, August 7th.
Check Out Our Latest Stock Report on SGRY Hedge Funds Weigh In On Surgery Partners Surgery Partners Trading Down 0.9 % Shares of Surgery Partners stock opened at $31.92 on Monday.
The stock has a fifty day simple moving average of $30.62 and a 200 day simple moving average of $27.64.
Surgery Partners has a 12-month low of $22.05 and a 12-month high of $36.92.
The company has a market capitalization of $4.06 billion, a P/E ratio of 45.94, a price-to-earnings-growth ratio of 2.
50 and a beta of 2.76. The company has a current ratio of 1.
83, a quick ratio of 1.69 and a debt-to-equity ratio of 0.96.
Surgery Partners ( NASDAQ:SGRY – Get Free Report ) last announced its quarterly earnings results on Tuesday, August 6th. The company reported $0.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.
20 by $0.01. The business had revenue of $762.
10 million during the quarter, compared to the consensus estimate of $735.94 million. Surgery Partners had a positive return on equity of 2.
96% and a negative net margin of 1.17%. Surgery Partners’s revenue was up 14.
2% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.25 earnings per share.
On average, sell-side analysts anticipate that Surgery Partners will post 0.86 earnings per share for the current fiscal year. About Surgery Partners ( Get Free Report Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States.
The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. Read More Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter .
.
